ACP5 and neoplasm: However, verteporfin‐treated mice displayed decreased bone‐metastases, reduced tumor burden, and fewer TRAP+‐osteoclasts along the bone‐tumor interface, consequently resulting in the longer survival of bone‐metastatic mice (Figure 8C).